PAR-2 transcription is known to be modulated by inflammatory transcription factors such as NF-κB [24], AP-1 [64], and STAT3 [65], all of which are strongly implicated in CRC progression and inflammation [66,67]. This evidence concerns the gene F2RL1 and colorectal carcinoma.